EUVIMEDEUVIMED entdecken
Crossref

Novel Ruthenium(II) Coordination-Enhanced Cytotoxic Potency of Pyrazine-2-carbohydrazide Schiff Bases: Synthesis, Characterisation, In-vitro and Docking Studies

Shivaraj S Dolli, Laxmi A Jagatap, Ramesh Vadavi, Tathagata Chakraborthy, Oruganti Anjaneyulu, Kalagouda Gudasi

IOSR Journal of Applied Chemistry · 2026-09 · 19 (9) · 06-33

DOI: 10.9790/5736-1909010633 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IOSR Journal of Applied Chemistry, 2026-09. Verfasst von Shivaraj S Dolli und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Owing to their superior biocompatibility, tunable coordination chemistry, and selective accumulation in tumor tissues, ruthenium(II) complexes have emerged as potential competitors for platinum-based chemotherapy drugs. Building on the anticancer potential of pyrazine-2-carbohydrazide scaffolds, three novel Schiff base ligands (L1- L3) bearing electronically distinct imine-bound aryl substituents (4,4-dichlorobenzophenyl, 4-chlorobenzophenyl, and 2-aminobenzophenyl, respectively) were synthesised, together with their corresponding octahedral ruthenium(II) complexes [RuL1-RuL3] featuring bidentate N,N-coordination through the pyrazine and imine nitrogen donors. All compounds were characterised by ¹H/¹³C NMR, FT-IR, UV-Visible, and mass spectrometry, while single-crystal X-ray diffraction of L1 and L3 (monoclinic, P2₁/n and P2₁/c, respectively) unambiguously confirmed the ligand molecular structures. Cytotoxic evaluation against Caco-2 human colorectal adenocarcinoma cells by the MTT assay revealed concentration- and time-dependent antiproliferative effects, with IC₅₀ values decreasing from 121.79–168.55 µg/mL (free ligands, 24 h) to 70.07–88.91 µg/mL (all compounds, 48 h). Ruthenium coordination markedly accelerated cytotoxic onset: at 24 h, RuL1 (IC₅₀ = 106.26 µg/mL) and RuL3 (111.74 µg/mL) were the most potent, whereas by 48 h, RuL2 (70.07 µg/mL) and RuL3 (74.54 µg/mL) sustained superior activity, indicating ligand-dependent kinetics of action. Molecular docking of L1-L3 against EGFR (1M17), PI3Kα (4JPS), and Bcl-2 (4LXD) yielded binding energies of −8.1 to −8.9 kcal/mol, with ligand efficiency values of −0.33 to −0.36; interaction analysis showed that hydrogen-bonding and π-cation/π-stacking networks, rather than binding-pocket size, governed the affinity trends across targets, mirroring the substituentdependent SAR observed in the cytotoxicity data. Collectively, these findings identify pyrazine-2-carbohydrazidebased ruthenium(II) complexes as multi-target-compatible scaffolds - engaging EGFR-, PI3Kα-, and Bcl-2-linked pathways — warranting further development as colorectal cancer therapeutics.

Zitieren

APA

Dolli, S. S., Jagatap, L. A., Vadavi, R., Chakraborthy, T., Anjaneyulu, O., & Gudasi, K. (2026). Novel Ruthenium(II) Coordination-Enhanced Cytotoxic Potency of Pyrazine-2-carbohydrazide Schiff Bases: Synthesis, Characterisation, In-vitro and Docking Studies. IOSR Journal of Applied Chemistry, 19(9), 06-33. https://doi.org/10.9790/5736-1909010633

Vancouver

Dolli SS, Jagatap LA, Vadavi R, Chakraborthy T, Anjaneyulu O, Gudasi K. Novel Ruthenium(II) Coordination-Enhanced Cytotoxic Potency of Pyrazine-2-carbohydrazide Schiff Bases: Synthesis, Characterisation, In-vitro and Docking Studies. IOSR Journal of Applied Chemistry. 2026;19(9):06-33. doi:10.9790/5736-1909010633

BibTeX
@article{Dolli2026,
  author = {Dolli, Shivaraj S and Jagatap, Laxmi A and Vadavi, Ramesh and Chakraborthy, Tathagata and Anjaneyulu, Oruganti and Gudasi, Kalagouda},
  title = {Novel Ruthenium(II) Coordination-Enhanced Cytotoxic Potency of Pyrazine-2-carbohydrazide Schiff Bases: Synthesis, Characterisation, In-vitro and Docking Studies},
  journal = {IOSR Journal of Applied Chemistry},
  year = {2026},
  volume = {19},
  number = {9},
  pages = {06--33},
  doi = {10.9790/5736-1909010633}
}
Kostenlos starten →